These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1909 related items for PubMed ID: 30529829

  • 1. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
    Kim YH, Her AY, Jeong MH, Kim BK, Lee SY, Hong SJ, Shin DH, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
    [Abstract] [Full Text] [Related]

  • 2. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH, Her AY, Jeong MH, Kim BK, Lee SY, Hong SJ, Shin DH, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
    [Abstract] [Full Text] [Related]

  • 3. ST-elevation versus non-ST-elevation myocardial infarction after combined use of statin with renin-angiotensin system inhibitor: Data from the Korea Acute Myocardial Infarction Registry.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Cardiol J; 2022 Feb; 29(4):647-659. PubMed ID: 33634844
    [Abstract] [Full Text] [Related]

  • 4. A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Atherosclerosis; 2019 Oct; 289():109-117. PubMed ID: 31491742
    [Abstract] [Full Text] [Related]

  • 5. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention.
    Byun JK, Choi BG, Rha SW, Choi SY, Jeong MH, Other Korea Acute Myocardial Infarction Registry (KAMIR) investigators.
    Atherosclerosis; 2018 Oct; 277():130-135. PubMed ID: 30212681
    [Abstract] [Full Text] [Related]

  • 6. Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Shin DH, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Am J Cardiovasc Drugs; 2019 Aug; 19(4):403-414. PubMed ID: 30788675
    [Abstract] [Full Text] [Related]

  • 7. ST-segment elevation versus non-ST-segment elevation myocardial infarction in current smokers after newer-generation drug-eluting stent implantation.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Lee SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Medicine (Baltimore); 2021 Dec 10; 100(49):e28214. PubMed ID: 34889307
    [Abstract] [Full Text] [Related]

  • 8. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G, Harari R, Baber U, Sartori S, Stone GW, Leon MB, Windecker S, Serruys PW, Kastrati A, Von Birgelen C, Kimura T, Stefanini GG, Dangas GD, Wijns W, Steg PG, Morice MC, Camenzind E, Weisz G, Smits PC, Sorrentino S, Sharma M, Farhan S, Faggioni M, Kandzari D, Galatius S, Jeger RV, Valgimigli M, Itchhaporia D, Mehta L, Kim HS, Chieffo A, Mehran R.
    JAMA Cardiol; 2017 Aug 01; 2(8):855-862. PubMed ID: 28658478
    [Abstract] [Full Text] [Related]

  • 9. Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Medicine (Baltimore); 2021 Aug 13; 100(32):e26947. PubMed ID: 34397947
    [Abstract] [Full Text] [Related]

  • 10. Different Statin Effects of ST-elevation Versus Non-ST-Elevation Acute Myocardial Infarction After Stent Implantation.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Am J Med Sci; 2020 Mar 13; 359(3):156-167. PubMed ID: 32089157
    [Abstract] [Full Text] [Related]

  • 11. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.
    Baek JY, Kang TS, Rha SW, Choi BG, Park SH, Jeong MH.
    Coron Artery Dis; 2018 Aug 13; 29(5):416-422. PubMed ID: 29708887
    [Abstract] [Full Text] [Related]

  • 12. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D, Sato A, Hoshi T, Maruta S, Misaki M, Kakefuda Y, Watabe H, Hiraya D, Sakai S, Kawabe M, Takeyasu N, Aonuma K.
    J Cardiol; 2014 Nov 13; 64(5):377-83. PubMed ID: 24685689
    [Abstract] [Full Text] [Related]

  • 13. ACE Inhibitors Versus ARBs in Patients With NSTEMI With Preserved LV Systolic Function Who Underwent PCI With New Generation Drug-Eluting Stents.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Angiology; 2020 Feb 13; 71(2):139-149. PubMed ID: 31694385
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention.
    Choi SY, Choi BG, Rha SW, Byun JK, Shim MS, Li H, Mashaly A, Choi CU, Park CG, Seo HS, Oh DJ, Jeong MH, Other Korea Acute Myocardial Infarction Registry (KAMIR) investigators.
    Int J Cardiol; 2017 Dec 15; 249():48-54. PubMed ID: 28867244
    [Abstract] [Full Text] [Related]

  • 15. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(2):E40-E55. PubMed ID: 31423723
    [Abstract] [Full Text] [Related]

  • 16. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.
    JACC Cardiovasc Interv; 2013 Dec 15; 6(12):1242-9. PubMed ID: 24355114
    [Abstract] [Full Text] [Related]

  • 17. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
    Harjai KJ, Sattur S, Orshaw P, Boura J.
    J Interv Cardiol; 2012 Feb 15; 25(1):28-36. PubMed ID: 21981467
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP, Wang LF, Liu Y, Li KB, Xu L, Li WM, Ni ZH, Xia K, Zhang ZY, Yang XC.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul 24; 48(7):600-607. PubMed ID: 32842271
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ, Yang M.
    Chin Med J (Engl); 2012 Aug 24; 125(16):2803-6. PubMed ID: 22932070
    [Abstract] [Full Text] [Related]

  • 20. Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention.
    Park H, Kim HK, Jeong MH, Cho JY, Lee KH, Sim DS, Yoon NS, Yoon HJ, Hong YJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kim YJ, Cho MC, Kim CJ, Korea Acute Myocardial Infarction Registry Investigators.
    J Cardiol; 2017 Jan 24; 69(1):216-221. PubMed ID: 27141820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 96.